Home LiteratureArticle Details
PMID: 18691744 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Disease-specific induced pluripotent stem cells.

Cell ·Vol. 134 ·No. 5 ·2008-09-05 ·Pages 877-86

Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ

Abstract

Tissue culture of immortal cell strains from diseased patients is an invaluable resource for medical research but is largely limited to tumor cell lines or transformed derivatives of native tissues. Here we describe the generation of induced pluripotent stem (iPS) cells from patients with a variety of genetic diseases with either Mendelian or complex inheritance; these diseases include adenosine deaminase deficiency-related severe combined immunodeficiency (ADA-SCID), Shwachman-Bodian-Diamond syndrome (SBDS), Gaucher disease (GD) type III, Duchenne (DMD) and Becker muscular dystrophy (BMD), Parkinson disease (PD), Huntington disease (HD), juvenile-onset, type 1 diabetes mellitus (JDM), Down syndrome (DS)/trisomy 21, and the carrier state of Lesch-Nyhan syndrome. Such disease-specific stem cells offer an unprecedented opportunity to recapitulate both normal and pathologic human tissue formation in vitro, thereby enabling disease investigation and drug development.

MeSH Terms
Bone Marrow Cells/cytology Cell Line Fibroblasts/cytology Genetic Diseases, Inborn/pathology Humans Karyotyping Mesenchymal Stem Cells/cytology Mutation Pluripotent Stem Cells/cytology
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Park In-Hyun
Department of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Arora Natasha
Huo Hongguang
Maherali Nimet
Ahfeldt Tim
Shimamura Akiko
Lensch M William
Cowan Chad
Hochedlinger Konrad
Daley George Q
References (32)
32 references, click to expand
  1. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10544-7 PMID: 1961718
  2. The four ages of Down syndrome.
    Eur J Public Health. 2007 Apr;17(2):221-5 PMID: 16857692
  3. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera.
    Cell Stem Cell. 2007 Sep 13;1(3):253-8 PMID: 18371359
  4. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia.
    Nat Genet. 1996 Apr;12(4):448-51 PMID: 8630504
  5. Chromosome 21 and down syndrome: from genomics to pathophysiology.
    Nat Rev Genet. 2004 Oct;5(10):725-38 PMID: 15510164
  6. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.
    Cell. 1987 Nov 6;51(3):503-12 PMID: 2822260
  7. Generation of human-induced pluripotent stem cells.
    Nat Protoc. 2008;3(7):1180-6 PMID: 18600223
  8. Mutations in the SBDS gene in acquired aplastic anemia.
    Blood. 2007 Aug 15;110(4):1141-6 PMID: 17478638
  9. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.
    Nucleic Acids Res. 1988 Dec 9;16(23):11141-56 PMID: 3205741
  10. The art and design of genetic screens: mammalian culture cells.
    Nat Rev Genet. 2004 Mar;5(3):179-89 PMID: 14970820
  11. Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease.
    Hum Mol Genet. 1993 Jun;2(6):637 PMID: 8353483
  12. Human embryonic stem cell derivation from poor-quality embryos.
    Nat Biotechnol. 2008 Feb;26(2):212-4 PMID: 18223642
  13. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
  14. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.
    Cell. 2008 Feb 22;132(4):661-80 PMID: 18295582
  15. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Science. 2004 Oct 22;306(5696):687-90 PMID: 15499018
  16. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction.
    Hum Genet. 1990 Nov;86(1):45-8 PMID: 2253937
  17. Reprogramming of human somatic cells to pluripotency with defined factors.
    Nature. 2008 Jan 10;451(7175):141-6 PMID: 18157115
  18. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.
    Cell Stem Cell. 2008 Mar 6;2(3):230-40 PMID: 18371448
  19. The Shwachman-Diamond SBDS protein localizes to the nucleolus.
    Blood. 2005 Aug 15;106(4):1253-8 PMID: 15860664
  20. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.
    Nat Neurosci. 2007 May;10(5):608-14 PMID: 17435754
  21. Generation of human induced pluripotent stem cells from dermal fibroblasts.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8 PMID: 18287077
  22. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy.
    Cell. 2002 Apr 5;109(1):17-27 PMID: 11955443
  23. A three-allele restriction-fragment-length polymorphism at the hypoxanthine phosphoribosyltransferase locus in man.
    Proc Natl Acad Sci U S A. 1983 Jul;80(13):4035-9 PMID: 6306659
  24. Two new mutations at the adenosine deaminase (ADA) locus (Q254X and del nt1050-54) unusual for not being missense mutations.
    Hum Mutat. 1993;2(4):320-3 PMID: 8401541
  25. Human embryonic stem cell lines with genetic disorders.
    Reprod Biomed Online. 2005 Jan;10(1):105-10 PMID: 15705304
  26. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells.
    Nature. 1987 Dec 10-16;330(6148):576-8 PMID: 3683574
  27. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
    Cell Stem Cell. 2008 Feb 7;2(2):151-9 PMID: 18371436
  28. Targeted mutation of the Hprt gene in mouse embryonic stem cells.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8583-7 PMID: 3186749
  29. Experience and strategy for the molecular testing of Duchenne muscular dystrophy.
    J Mol Diagn. 2005 Aug;7(3):317-26 PMID: 16049303
  30. Induced pluripotent stem cell lines derived from human somatic cells.
    Science. 2007 Dec 21;318(5858):1917-20 PMID: 18029452
  31. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.
    Hum Mol Genet. 1997 Feb;6(2):301-9 PMID: 9063751
  32. Genetics. The critical region in trisomy 21.
    Science. 2004 Oct 22;306(5696):619-21 PMID: 15499000
Article Info
Journal
Cell
Abbr.
Cell
ISSN
1097-4172
Published
2008-09-05
Epub
2008-00-07
Pages
877-86
Language
English
Region
United States
NLM ID
0413066
PMCID
PMC2633781
Subset
IM
Grants
NIDDK NIH HHS · R01 DK059279 · United States
NIH HHS · DP1 OD000256 · United States
NIDDK NIH HHS · R01 DK059279-08 · United States
Howard Hughes Medical Institute · United States
NHLBI NIH HHS · R01 HL079582 · United States
NIH HHS · DP1 OD000256-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]